Frederick Barrett
Senior Research Scientist
Data updated
Research Footprint
Frederick Barrett appears in 43 tracked papers (2015–2026), most studied alongside Psilocybin, LSD and Mescaline, across Depressive Disorders, Anxiety Disorders and Healthy Volunteers.
Most-cited paper: Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (1236 citations).
Frequent co-authors: Roland Griffiths, Matthew Johnson and Nathan Sepeda.
Background & Research
Frederick S. Barrett is a psychologist and neuroscientist broadly affiliated with the field of clinical psychedelic research, best known for collaborative work with major centres in the United States on psilocybin and other serotonergic compounds. He has played a prominent role in trials and human laboratory studies exploring therapeutic applications of psychedelics, as well as mechanistic investigations using neuroimaging and receptor-occupancy approaches. Barrett is a frequent co-author with investigators such as Roland R. Griffiths and Matthew W. Johnson and has contributed to both clinical trial reports and methodological papers that seek to strengthen rigour in psychedelic research.
Barrett's substantive contributions include the development and validation of psychometric instruments used to quantify acute subjective phenomena (for example, measures of challenging experiences and psychological insight), analyses of safety signals (including work examining coadministration risks such as seizures associated with lithium), and experimental studies of music-evoked brain activity under LSD and psilocybin. He has also contributed to naturalistic cohort studies and to comparative cognition research examining hallucinogen users versus controls. Across these domains he has emphasised careful measurement, reproducible methods, and the integration of subjective-report instruments with neurobiological data to advance understanding of therapeutic mechanisms and safety considerations in psychedelic-assisted interventions.
Key Impact
Frederick S. Barrett is a leading researcher in contemporary psychedelic science noted for developing psychometric tools, characterising challenging and insightful psychedelic experiences, and contributing to neuroimaging and safety research on psilocybin and other classic psychedelics.
Collaboration Network
70 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Frederick Barrett is associated with.
Johns Hopkins University
academicThe Centre for Psychedelic and Consciousness Research focuses on how psychedelics affect behavior, cognition, brain function, and biological health markers. They have been at the forefront of demonstrating the safety and efficacy of psychedelics for mental disorders, expanding their focus into psilocybin research across multiple mental health conditions, including smoking cessation, major depressive disorder, and cancer-related anxiety.
View stakeholder →Johns Hopkins Center for Psychedelic and Consciousness Research
A research center within Johns Hopkins University (School of Medicine) that conducts scientific studies on psychedelic compounds, their effects on brain function and consciousness, and their therapeutic potential for mental health conditions.
View stakeholder →